Introduction {#s1}
============

Continuous intrathecal baclofen infusion therapy (IBT) makes use of an implanted programmable pump to deliver baclofen, a derivative of gamma-aminobutyric acid (GABA), directly to the cerebral spinal fluid. IBT has been demonstrated to be effective in controlling spasticity and muscle spasms following spinal cord injury \[[@R01], [@R02]\]. Patients with spinal cord injury may also suffer from dysphagia or insufficient oral intake, requiring long-term enteral tube nutrition in some cases. Percutaneous endoscopic gastrostomy (PEG) has been established as a minimally invasive procedure to achieve percutaneous tube feeding for long-term enteral nutrition \[[@R03], [@R04]\]. Although the presence of a PEG tube has been reported as the greatest significant predictor of infection in patients undergoing IBT pump implantation, there is limited literature regarding the safety or rate of infection among patients with IBT undergoing PEG \[[@R05]\]. We herein report the successful PEG tube placement in a 68-year-old man with a previously implanted IBT pump.

Case Report {#s2}
===========

A 68-year-old man was referred to our hospital to undergo PEG for long-term enteral tube feeding. About one and a half years ago, he encountered a traffic accident which gave him a cerebral contusion and diffuse axonal injury. He was left with quadriplegia and dysphagia, being tube-fed via a nasogastric tube since the accident. The patient experienced severe muscle spasms from his spinal cord injury and about a year ago had an IBT pump implanted subcutaneously into his left inguinal area to help alleviate his symptoms.

Although muscle and articular contracture was rather severe, physical examination was otherwise unremarkable. Laboratory data were mostly within the normal range and abdominal CT evaluation indicated that PEG was possible. The patient underwent PEG using the introducer technique with a 20 Fr size catheter kit (Intolief PEG kit by Create Medic Co., Ltd, Yokohama, Japan). After determining the puncture site, local anesthesia was applied and gastropexy was performed using a gastropexy device ([Fig. 1a](#F1){ref-type="fig"}). Gastropexy procedure was repeated at least three times surrounding the intended puncture site in a triangular pattern before the puncture needle/trocar was inserted ([Fig. 1b](#F1){ref-type="fig"}). The puncture needle was then removed ([Fig. 1c](#F1){ref-type="fig"}) and a 20 Fr size gastrostomy tube was inserted into the gastric lumen ([Fig. 1d](#F1){ref-type="fig"}). No problems were encountered during the procedure.

![Endoscopic imaging of PEG using the introducer technique in this patient. (a) After determining the puncture site, local anesthesia was applied and gastropexy was performed using a gastropexy device. (b) Gastropexy procedure was repeated at least three times surrounding the intended puncture site in a triangular pattern before the puncture needle/trocar was inserted. (c) The puncture needle was then removed. (d) A 20 Fr size gastrostomy tube was inserted into the gastric lumen.](gr-10-132-g001){#F1}

Postoperative clinical course was also uneventful and there was no peristomal infection at 1 week after the procedure. After achieving stable intermittent gastric feeding via the PEG tube, the patient was discharged 10 days after the procedure without further complications. Follow-up on day 30 after the procedure confirmed that there were no adverse events related to the IBT pump implant. An abdominal radiograph taken on day 2 after the procedure showed the position of the gastrostomy tube ([Fig. 2](#F2){ref-type="fig"}, yellow arrow) relative to the implanted IBT pump ([Fig. 2](#F2){ref-type="fig"}, red arrow).

![Abdominal radiograph revealing the position of the PEG catheter (yellow arrow) relative to the implanted IBT pump (red arrow).](gr-10-132-g002){#F2}

Discussion {#s3}
==========

Our case demonstrated that PEG is a procedure that can be safely performed in a patient with a previous IBT pump implantation. Although previous PEG tube placement seems to contribute to IBT pump-related infections, the route of infection remains unclear. However, it should be noted that the most common causative agent in IBT pump-related infection (which may occur in up to 9% of implanted patients) has been shown to be *Staphylococcus aureus* \[[@R05], [@R06]\], which is common in skin and soft tissue infections \[[@R07]\]. Since peristomal infection has also been reported as the most common adverse event after PEG, it is quite plausible that IBT pump-related infection after PEG tube placement occurs mainly through the skin or connective tissue \[[@R08]\]. The occurrence of implantation site infection is not something that can be taken lightly because it may develop to meningitis if not managed properly \[[@R09]\].

Although systemic antimicrobial prophylaxis has been shown to reduce the incidence of post-PEG peristomal infection, it does not totally eliminate the risk of infection \[[@R10]\]. PEG using the introducer technique, in which the gastrostomy tube is inserted without passing through the oral cavity, has also been associated with lower peristomal infection rates compared to conventional pull/push techniques \[[@R11]\]. Nevertheless, this technique is not widely used because the size of the PEG catheter employed is often small. Recently, large-caliber tubes using this technique, such as in our case, can also be safely inserted without increasing the risk of peristomal infection \[[@R12]\]. In our patient, the introducer technique was used along with systemic antimicrobial prophylaxis.

In conclusion, PEG performed after IBT implantation seems to be reasonably safe although there are no large studies we are aware of to confirm this. If infection does occur mainly via the skin and soft tissue, further measures to avoid IBT pump-related infection after PEG tube placement such as the choice of tube insertion technique as well as systematic antibiotics administration should be strongly considered.
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